Stronger Warning for Two Diabetes Drugs.
Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: daschenbrenner@ndm.edu.
Diane S
DS
Aschenbrenner
D058186:Acute Kidney Injury / Q000139:chemically induced; D001559:Benzhydryl Compounds / Q000009:adverse effects*; D000068896:Canagliflozin / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D005960:Glucosides / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents; D000068896:Canagliflozin; C529054:dapagliflozin